Brian Jahns

Brian Jahns serves as the President and Chief Operating Officer at Vasomune Therapeutics, Inc. since May 2023. With extensive experience in the biotechnology and pharmaceutical sectors, Brian holds the position of Managing Director and Consultant in Oncology and Rare Diseases at DynEq Consulting Inc. since July 2016, providing strategic insights for early-stage biotech companies. Brian has served on the board of directors for both N-Zyme Biomedical Inc. and Sauvie BiKE LLC, and has held significant roles at Trillium Therapeutics Inc. as Senior Vice-President for Commercial and Business Development. Prior experience includes leadership at Roche, where Brian was Vice-President of Sales and Marketing in Oncology as well as in various other roles within the company. Brian's academic credentials include a Doctor of Pharmacy from Wayne State University and additional degrees from Queen's University, Western University, INSEAD, and the Saïd Business School at the University of Oxford.